Pregnane X Receptor and Constitutive Androstane Receptor at the Crossroads of Drug Metabolism and Energy Metabolism

被引:104
|
作者
Gao, Jie [1 ,2 ]
Xie, Wen [1 ,2 ,3 ]
机构
[1] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA
基金
美国国家卫生研究院;
关键词
ACTIVATED PROTEIN-KINASE; THYROID-HORMONE METABOLISM; HEPATIC CYTOCHROME-P450 REDUCTASE; NUCLEAR RECEPTOR; MOUSE-LIVER; CONDITIONAL DELETION; HUMAN HEPATOCYTES; ENZYME INDUCERS; GENE-EXPRESSION; TARGET GENES;
D O I
10.1124/dmd.110.035568
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pregnane X receptor (PXR) and the constitutive androstane receptor (CAR) are two closely related and liver-enriched nuclear hormone receptors originally defined as xenobiotic receptors. PXR and CAR regulate the transcription of drug-metabolizing enzymes and transporters, which are essential in protecting our bodies from the accumulation of harmful chemicals. An increasing body of evidence suggests that PXR and CAR also have an endobiotic function that impacts energy homeostasis through the regulation of glucose and lipids metabolism. Of note and in contrast, disruptions of energy homeostasis, such as those observed in obesity and diabetes, also have a major impact on drug metabolism. This review will focus on recent progress in our understanding of the integral role of PXR and CAR in drug metabolism and energy homeostasis.
引用
收藏
页码:2091 / 2095
页数:5
相关论文
共 50 条
  • [41] The Role of Gut Microbes in Regulating the Constitutive Androstane Receptor and Metabolism.
    Poteres, Elesa
    Ibay, Iara
    Alt, Lauren
    Keeler, Kelly
    Pytynia, Matt
    Isabelli, Allison
    Martinez-Guryn, Kristina
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2019, 55 : S41 - S41
  • [42] Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine
    De Mattia, Elena
    Cecchin, Erika
    Roncato, Rossana
    Toffoli, Giuseppe
    PHARMACOGENOMICS, 2016, 17 (14) : 1547 - 1571
  • [43] Selective Phthalate Activation of Naturally Occurring Human Constitutive Androstane Receptor Splice Variants and the Pregnane X Receptor
    DeKeyser, Joshua G.
    Laurenzana, Elizabeth M.
    Peterson, Eric C.
    Chen, Tao
    Omiecinski, Curtis J.
    TOXICOLOGICAL SCIENCES, 2011, 120 (02) : 381 - 391
  • [44] Transactivation Assays to Assess Canine and Rodent Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) Activation
    Pinne, Marija
    Ponce, Elsa
    Raucy, Judy L.
    PLOS ONE, 2016, 11 (10):
  • [45] Quantitation of CYP2B6, constitutive androstane receptor, and pregnane X receptor mRNA levels
    Hesse, LM
    Court, MH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 685 - 685
  • [46] Function and evolution of the pregnane X receptor: A nuclear hormone receptor that regulates drug and endobiotic metabolism.
    Krasowski, MD
    Yasuda, K
    Schuetz, EG
    Di Rienzo, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) : 460 - 461
  • [47] Regulation of Hepatic Long Noncoding RNAs by Pregnane X Receptor and Constitutive Androstane Receptor Agonists in Mouse Liver
    Dempsey, Joseph L.
    Cui, Julia Yue
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (03) : 329 - 339
  • [48] The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity
    Zhang, J
    Huang, WD
    Qatanani, M
    Evans, RM
    Moore, DD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 49517 - 49522
  • [49] Ochratoxin A activates human pregnane X receptor, constitutive androstane receptor and Aryl hydrocarbon receptor in primary cultures of human hepatocytes
    Ayed, I.
    Hassen, W.
    Maurel, P.
    Pascussi, J. M.
    Bacha, H.
    FEBS JOURNAL, 2009, 276 : 176 - 177
  • [50] Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barriers
    Whyte-Allman, Sana-Kay
    Hoque, Md Tozammel
    Jenabian, Mohammad-Ali
    Routy, Jean-Pierre
    Bendayan, Reina
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 363 (03): : 324 - 335